HBIO
Harvard Bioscience Inc
Price:  
3.18 
USD
Volume:  
126,516.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBIO Relative Valuation

-291.4%
Upside

As of 2024-07-19, the Relative Valuation of Harvard Bioscience Inc (HBIO) is (6.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.18 USD, the upside of Harvard Bioscience Inc based on Relative Valuation is -291.4%.

The range of the Relative Valuation is (5.88) - (6.32) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 29.2x - 32.3x 30.7x
Forward P/E multiples 27.6x - 31.4x 29.8x
Fair Price (5.88) - (6.32) (6.09)
Upside -284.9% - -298.7% -291.4%
3.18 USD
Stock Price
(6.09) USD
Fair Price

HBIO Relative Valuation - Historical P/E Data

Date P/E
2024-07-19 -15.57
2024-07-18 -15.82
2024-07-17 -17.21
2024-07-16 -17.61
2024-07-15 -16.51
2024-07-12 -16.21
2024-07-11 -16.31
2024-07-10 -14.32
2024-07-09 -13.83
2024-07-08 -13.85
2024-07-05 -13.53
2024-07-03 -13.78
2024-07-02 -13.88
2024-07-01 -13.83
2024-06-28 -14.17
2024-06-27 -14.42
2024-06-26 -14.37
2024-06-25 -14.47
2024-06-24 -14.17
2024-06-21 -14.03
2024-06-20 -14.27
2024-06-18 -14.62
2024-06-17 -14.52
2024-06-14 -14.40
2024-06-13 -14.47
2024-06-12 -14.82
2024-06-11 -13.78
2024-06-10 -13.93
2024-06-07 -14.62
2024-06-06 -14.82
2024-06-05 -15.27
2024-06-04 -15.57
2024-06-03 -15.82
2024-05-31 -15.77
2024-05-30 -15.52
2024-05-29 -15.42
2024-05-28 -15.82
2024-05-24 -15.72
2024-05-23 -15.82
2024-05-22 -16.41
2024-05-21 -16.26
2024-05-20 -16.26
2024-05-17 -16.76
2024-05-16 -17.11
2024-05-15 -17.16
2024-05-14 -17.06
2024-05-13 -16.86
2024-05-10 -17.56
2024-05-09 -17.71
2024-05-08 -18.30